Mistakes, misunderstandings and controversies in diabetes: A review and personal account
- PMID: 24843414
- PMCID: PMC4008022
- DOI: 10.1111/j.2040-1124.2010.00012.x
Mistakes, misunderstandings and controversies in diabetes: A review and personal account
Abstract
A number of controversies in diabetes have had too little attention. I discuss the following issues: (i) drug therapy; (ii) genetics; (iii) antihypertensive treatment in patients with normoalbuminuria and with abnormal albuminuria; (iv) insulin analogs; (v) cancer in diabetes; (vi) hypophysectomy; (vii) renal biopsy; (viii) low protein diet; and (ix) glycated hemoglobin. A closer look at these items is required in order to have a more realistic picture of diabetes research. A scheme of other controversies is also provided. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00012.x, 2010).
Keywords: Drug and dietary therapy; Glycated hemoglobin; Glycemic control.
References
-
- Mogensen CE. Twelve shifting paradigms in diabetic renal disease and hypertension. Diabetes Res Clin Pract 2008; 825: 2–59 - PubMed
-
- Østerby R. Morphometric studies of peripheral glomerular basement membrane in early juvenile diabetes. Diabetologia 1972; 8: 84–88 - PubMed
-
- Tattersall R. The Biography. Oxford University Press, Oxford, 2009.
-
- The Advance Collaborative Group . Intensive blood glucose control and vascular outcome in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–2572 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
